AMS-PHPT Research Collaboration has been partnering with Penta since 2006 on multiple clinical trials.  Penta is an international independent scientific network with its headquarters in Padova, Italy, dedicated to child health. The Penta network is the result of a passionate collaboration between healthcare professionals and researchers in more than 110 centres across 31 countries around the world (https://penta-id.org/)

AMS-PHPT Clinical Network Sites in Thailand participating in Penta trials: 

1. Prapokklao Hospital
2. Phayao Hospital
3. Chiangrai Prachanukroh Hospital
4. Nakornping Hospital
5. Kalasin Hospital
6. Khon Kaen Hospital
7. Mahasarakam Hospital

Ongoing studies:

D3 (PENTA 21): A randomised non-inferiority trial with nested PK to assess DTG/3TC fixed dose formulations for the maintenance of virological suppression in children with HIV infection aged 2 to <15 years old (https://penta-id.org/hiv/d3/)

ODYSSEY (PENTA 20): A randomised trial of dolutegravir (DGT)-based antiretroviral therapy vs. standard of care (SOC) in children with HIV infection starting first-line or switching to second-line ART (https://penta-id.org/hiv/odyssey-penta-20/)